glp-1 review article and the kidney: from physiology to pharmacology and outcomes in diabetes Ozempic GLP-1 Pitfalls and Natural

Semaglutide GLP-1 , Ozempic, Wegovy, and Mounjaro are all medications that have become increasingly popular in medical weight management

Lilly expects to apply for FDA approval of the new drug, orforglipron, by the end of the year

Researchers believe this triple-hormone approach may explain why retatrutide appears to cause more weight loss than older drugs that target only one or two of these receptors

A non-injectable, non-stimulant alternative to GLP-1 drugs

Dermatologists believe this hair loss is caused by the sudden weight loss people go through on these drugs

Individuals with a BMI over 25 and metabolic concerns, or a BMI over 30, may be considered following a medical evaluation